Detection and characterization of defects in pharmaceutical cylindrical containers

US12259337B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12259337-B2
Application numberUS-202017032664-A
CountryUS
Kind codeB2
Filing dateSep 25, 2020
Priority dateJan 23, 2020
Publication dateMar 25, 2025
Grant dateMar 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An apparatus for inspecting a pharmaceutical cylindrical container made of glass or of a polymer is provided. A corresponding method for inspecting the pharmaceutical cylindrical container made of glass or of a polymer and to a bundle of pharmaceutical cylindrical containers made of glass or of a polymer is also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. An apparatus for inspecting a pharmaceutical cylindrical container made of glass or polymer, the apparatus comprising: a support device configured to support the pharmaceutical cylindrical container and rotate the pharmaceutical cylindrical container around a longitudinal axis; a light receiving unit comprising a main camera configured to acquire an image of the pharmaceutical cylindrical container; a light emitting unit comprising, with respect to the main camera, a bright field light source, a radial dark field light source, and an axial dark field light source; and a control unit configured to control the support device, the light emitting unit, and the light receiving unit to acquire a plurality of images of the pharmaceutical cylindrical container, the plurality of images comprising images taken when only the bright field light source is activated and when only the axial and/or radial dark field light sources are activated. 2. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a horizontal axis perpendicular to the longitudinal axis define a horizontal plane, wherein: the main camera has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less, and/or the bright field light source has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less, and/or the axial dark field light source has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 20° or less, and/or the radial dark field light source has a centerline that intersects the horizontal plane at an angle in a range selected from a group consisting of 100 or more and 90° or less, 450 or more and 90° or less, and 700 or more and 90° or less. 3. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that the longitudinal axis and a vertical axis perpendicular to the longitudinal axis define a vertical plane, wherein: the main camera has a centerline that intersects the vertical plane at an angle of 60° or more and 90° or less, 70° or more and 90° or less, and 80° or more and 90° or less, and/or the bright field light source has a centerline that intersects the vertical plane at an angle in a range selected from a group consisting of 60° or more and 90° or less, 70° or more and 90° or less, and 80° or more and 90° or less, and/or the axial dark field light source has a centerline that intersects the vertical plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 20° or less, and/or the radial dark field light source has a centerline that intersects the vertical plane at an angle in a range selected from a group consisting of 0° or more and 70° or less, 0° or more and 45° or less, and 0° or more and 20° or less. 4. The apparatus of claim 1 , wherein the support device supports the pharmaceutical cylindrical container so that a horizontal axis perpendicular to the longitudinal axis and a vertical axis perpendicular to the longitudinal axis intersect a middle of a cylindrical part of the pharmaceutical cylindrical container at a transversal plane, wherein: the main camera has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less, and/or the bright field light source has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 0° or more and 30° or less, 0° or more and 20° or less, and 0° or more and 10° or less, and/or the axial dark field light source has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 60° or more and 90° or less, 70° or more and 90° or less, and 80° or more and 90° or less, and/or the radial dark field light source has a centerline that intersects the transversal plane at an angle in a range selected from a group consisting of 0° or more and 70° or less, 0° or more and 45° or less, and 0° or more and 20° or less. 5. The apparatus of claim 1 , wherein the light receiving unit further comprises a plurality of cameras. 6. The apparatus of claim 5 , wherein the plurality of the cameras is between 5 to 25 cameras. 7. The apparatus of claim 1 , wherein the light emitting unit comprises a property selected from the group consisting of: the bright field light source having a light emitting plane that has a size in a range a range selected from a group consisting of 20 cm 2 to 2000 cm 2 , 15 cm 2 to 1000 cm 2 , and 25 cm 2 to 600 cm 2 ; the radial dark field light source having a light emitting plane that has a size in a range a range selected from a group consisting of 0.5 cm 2 to 2000 cm 2 , 0.8 cm 2 to 1000 cm 2 , and 1 cm 2 to 400 cm 2 ; the axial dark field light source having a light emitting plane that has a size in a range a range selected from a group consisting of 0.5 cm 2 to 1000 cm 2 , 0.8 cm 2 to 200 cm 2 , and 1.0 cm 2 to 64 cm 2 ; and any combinations thereof. 8. The apparatus of claim 1 , wherein the bright field light source, the radial dark field light source, and the axial dark field light source each comprise a light emitting plane, wherein: the light emitting planes have a property selected from the group consisting of: a color temperature between 2000 K and 7000 K, a color temperature between 3000 K to 6000 K, a color temperature between 4000 K to 5000 K, and combinations thereof, and/or the light emitting planes of the axial and the radial dark field light sources each have a luminous flux that are higher than a luminous flux of the light emitting plane of the bright field light source; and/or the support device has a distance between each of the light emitting planes that is in a range selected from a group consisting of 5 to 50 cm, 8 to 30 cm, 10 to 20 cm, and combinations thereof. 9. The apparatus of claim 1 , wherein the light emitting unit has a first light emitting plane and a second light emitting plane adjoining each other, wherein the first light emitting plane and the second light emitting plane intersect at an angle in a range selected from a group consisting of 10° to 80 °, 30° to 60°, and 40° to 50°. 10. The apparatus of claim 1 , wherein the support device comprises at least two support wheels and a friction wheel arranged such that the pharmaceutical cylindrical container is on the support wheels and is rotatable around the longitudinal axis by the friction wheel. 11. The apparatus of claim 1 , wherein the control unit is further configured to control the support device, the light emitting unit, and the light receiving unit to perform a task selected from a group consisting of: measure the pharmaceutical cylindrical container in 0.3 to 10 seconds; rotate the pharmaceutical cylindrical container 360° around the longitudinal axis; rotate the pharmaceutical cylindrical container in increments between 0.5° and 4°; rotate the pharmaceutical cylindrical container in between the image acquisitions; activate/deactivate the main camera based on the speed of a friction wheel; and any combinations thereof. 12. The apparatus of claim 1 , wherein the control unit controls t

Assignees

Inventors

Classifications

  • Inspecting transparent materials {or objects, e.g. windscreens (for conveyed flat sheet or rod G01N21/896)} · CPC title

  • Non-optical constructional details affecting optical inspection, e.g. cleaning mechanisms for optical parts, vibration reduction · CPC title

  • Arrangements or apparatus for facilitating the optical investigation · CPC title

  • G01N21/90Primary

    in a container or its contents (G01N21/91 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12259337B2 cover?
An apparatus for inspecting a pharmaceutical cylindrical container made of glass or of a polymer is provided. A corresponding method for inspecting the pharmaceutical cylindrical container made of glass or of a polymer and to a bundle of pharmaceutical cylindrical containers made of glass or of a polymer is also provided.
Who is the assignee on this patent?
Schott Pharma Schweiz Ag
What technology area does this patent fall under?
Primary CPC classification G01N21/9009. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).